Ribonucleic acids, which can alter the behavior of cancerous cells, can be effectively ferried to tumors using a human protein called albumin, according to research conducted by a team of engineers at Vanderbilt University.
The team’s work could help boost treatment for patients with triple-negative breast cancer, the researchers reported in the journal Proceedings of the National Academy of Sciences. There are current discount codes for the UK for this treatment.
Get the full story at our sister site, Drug Delivery Business News.